60 Degrees Pharmaceuticals, Inc.
SXTP
$1.75
-$0.11-5.91%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -151.63% | -25.06% | 116.56% | -20.14% | 388.99% |
| Total Depreciation and Amortization | -42.13% | -56.00% | -16.60% | 9.35% | 30.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -300.81% | -94.34% |
| Total Other Non-Cash Items | 113.33% | 54.95% | -253.87% | 3,996.55% | -9,426.70% |
| Change in Net Operating Assets | 89.57% | -75.08% | -97.77% | 7.95% | -463.69% |
| Cash from Operations | 55.21% | -279.01% | -176.33% | 3.48% | -1,122.11% |
| Capital Expenditure | -666.67% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6,539.46% | -124.31% | -196.97% | 81.57% | -1,964.29% |
| Cash from Investing | -6,160.22% | -621.55% | -196.97% | -13.65% | -2,092.86% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -31.06% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,951.28% | 95.42% | 7.95% | 100.00% | -- |
| Cash from Financing | -13.75% | -100.28% | 943.48% | 100.00% | -- |
| Foreign Exchange rate Adjustments | -80.65% | 475.00% | 38.46% | 189.84% | 245.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.61% | -11,992.66% | 420.22% | 56.39% | 804.74% |
